Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population

BACKGROUND: To investigate the predictive value of chemokine CCL27 for identifying early stage nasopharyngeal carcinoma (NPC) patients within a population seropositive for Epstein-Barr virus (EBV) capsid antigen-specific IgA (VCA-IgA). METHODS: CCL27 in plasma samples from 104 NPC patients, 112 VCA-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Min-jie, Xue, Ning, Wang, Xue-ping, Chi, Pei-dong, Liu, Yi-jun, Huang, Qi, Dai, Shu-qin, Liu, Wan-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751682/
https://www.ncbi.nlm.nih.gov/pubmed/29295705
http://dx.doi.org/10.1186/s12885-017-3718-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751682/
https://www.ncbi.nlm.nih.gov/pubmed/29295705
http://dx.doi.org/10.1186/s12885-017-3718-2

Ejemplares similares